MedTrace Logo

Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)

NCT00749398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2015-07-28

Study results available
· View outcomes & findings →

Summary

This is a national, multi-center, observational, prospective photographic atlas study in subjects who are treated with infliximab for moderate-to-severe psoriasis in daily clinic according to local country regulations and reimbursement.

Conditions

Interventions

BIOLOGICAL

Infliximab

According to local country regulations.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2010-09-30
Completion
2010-09-30

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00749398 on ClinicalTrials.gov